Ginkgo Bioworks and Centrient Pharmaceuticals Announce Expansion of Partnership Following Success of Initial Project to Bring Sustainable Innovation to the Generic API Space

RIJSWIJK, the Netherlands and BOSTON, USA, May 25, 2023 -- Centrient Pharmaceuticals ("Centrient"), the global business-to-business leader in sustainable antibiotics, next-generation statins and anti-fungals, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced they are expanding their existing partnership aimed at broadening Centrient's portfolio of environmentally friendly active pharmaceutical ingredients (APIs), following the success of previous work together.

Centrient Celebrates Earth Day 2023

Every April 22nd, stakeholders unite to advance sustainability and climate action to commemorate Earth Day. This year, Earth Day was celebrated under the “Invest In Our Planet” theme, highlighting the importance of solving climate change and other environmental issues. In Centrient, we continued our tree-planting tradition, collecting plastic and other litter and raising awareness about environmental issues in our partner schools and communities.

Centrient eliminated all single-use plastics in our offices